Kardigan, Inc. (KARD) Financials

KARD Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 721.8 million 106.3 million
March 31, 2026 348.2 million 648.8 million
June 30, 2025 ? ?
March 31, 2025 ? ?

KARD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -51.5 million 11.7 million
March 31, 2026 -59.4 million 5.4 million
June 30, 2025 -33.4 million 4.3 million
March 31, 2025 -21.9 million 2.9 million

KARD Net Income

No data available :(

KARD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 597.6 million - 9.6 million
March 31, 2026 287.1 million - 13.9 million
June 30, 2025 - - -
March 31, 2025 - - -

KARD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 93.5 million
March 31, 2026 62.3 million
June 30, 2025 ?
March 31, 2025 ?

KARD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 924000 55.2 million 17.8 million -
March 31, 2026 2.6 million 45.1 million 13.6 million -
June 30, 2025 2.1 million 35.8 million 21.3 million -
March 31, 2025 542000 18.8 million 7.3 million -

KARD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 2.2 million
March 31, 2026 - -
June 30, 2025 - -
March 31, 2025 - -

KARD

Price: $13.88

52 week price:
12.97
27.00

Earnings Per Share: -3.09 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.3 billion

Links: